The role of probiotics on each component of the metabolic syndrome and other cardiovascular risks

Expert Opinion on Therapeutic Targets

Volumn 19, Issue 8, 2015, Pages 1127-1138

  Miglioranza Scavuzzi, Bruna ^a   Miglioranza, Lucia Helena Da Silva ^a   Henrique, Fernanda Carla ^a   Pitelli Paroschi, Thanise ^a   Lozovoy, Marcell Alysson Batisti ^a   Simaõ, Andrea Name Colado ^a   Dichi, Isaias ^a  

^a UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Dysbiosis; dyslipidemia; gut microbiota; inflammation; insulin resistance; obesity

Indexed keywords

GLUCOSE; LIPID; PROBIOTIC AGENT;

BACTERIAL STRAIN; BIFIDOBACTERIUM; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CARDIOVASCULAR RISK; DYSBIOSIS; GLUCOSE HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; LACTOBACILLUS; LIPID BLOOD LEVEL; LIPID METABOLISM; METABOLIC SYNDROME X; MODULATION; NONHUMAN; OBESITY; REVIEW; ANIMAL; CARDIOVASCULAR DISEASES; COMPLICATION; DIETARY SUPPLEMENT; MICROBIOLOGY; PHYSIOLOGY; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; GASTROINTESTINAL MICROBIOME; HUMANS; METABOLIC SYNDROME X; PROBIOTICS; RISK FACTORS;

EID: 84937140721     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2015.1028361     Document Type: Review

References (96)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607
2. Wildman RP, McGinn AP, Kim M, et al. Empirical derivation to improve the definition of the Metabolic Syndrome in the evaluation of cardiovascular disease risk. Diabetes Care 2011;34:746-8
3. Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012;4:1095-119
4. Diamant M, Blaak EE, de Vos WM. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes Obes Rev 2011;12:272-81
5. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006;7:688-93
6. Quigley EMM. Gut Bacteria in Health and Disease. Gastroenterol Hepatol 2013;9:560-9
7. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-19
8. Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 2014;14:141-53
9. Delzenne NM, Cani PD. Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: potential interest of prebiotics. Int Dairy J 2010;20:277-80
10. Gøbel RJ, Larsen N, Jakobsen M, et al. Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome. J Pediatr Gastroenterol Nutr 2012;55:673-8
11. Alonso VR, Guarner F. Linking the gut microbiota to human health. Br J Nutr 2013;109:S21-6
12. Barreto FM, Simaõ AN, Morimoto HK, et al. Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome. Nutrition 2014;30:939-42
13. Kalliomaki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008;87:534-8
14. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004;101:15718-23
15. Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010;5:e9085 pathological states (diabetic/nondiabetic).
16. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470-81
17. FAO, WHO Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, Cordoba, Argentina, 1-4
18. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-72
19. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 2009;9:737-43
20. Ley RE, Bäckhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005;102:11070-5
21. Stenman LK, Holma R, Korpela R. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J Gastroenterol 2012;18:923-9
22. Teixeira TF, Collado MC, Ferreira CL, et al. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 2012;32:637-47
23. De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010;107:14691-6
24. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008;4:213-23
25. Murphy EF, Cotter PD, Healy S, et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010;12:1635-42
26. Nakamura NK, Omaye ST. Metabolic diseases and pro-and prebiotics: mechanistic insights. Nutr Metab 2012;9:1-9
27. Ghoshal S, Witta J, Zhong J, et al. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009;50:90-7
28. Lassenius MI, Pietilaïnen KH, Kaartinen K, et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011;34:1809-15
29. Sun L, Yu Z, Ye X, et al. A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 2010;33:1925-32
30. Haziot A, Ferrero E, Lin XY, et al. CD14-deficient mice are exquisitely insensitive to the effects of LPS. Prog Clin Biol Res 1995;392:349-51
31. Kitchens RL, Thompson PA. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 2005;11:225-9
32. Shi H, Kokoeva MV, Inouye K, et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116:3015-25
33. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91
34. Jensen MD, Haymond MW, Rizza RA, et al. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989;83:1168-73
35. Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Tolllike receptor 4. J Biol Chem 2001;276:16683-9
36. Andreasen AS, Larsen N, Pedersen-Skovsgaard T, et al. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 2010;104:1831-8
37. Hector J, Schwarzloh B, Goehring J, et al. TNF-alpha alters visfatin and adiponectin levels in human fat. Horm Metab Res 2007;39:250-5
38. Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009;58:1091-103
39. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270;26746-9
40. Dichi I, Simaõ ANC. Metabolic syndrome: new targets for an old problem. Expert Opin Ther Targets 2012;16:147-50
41. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007;380:24-30
42. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;8:941-6
43. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009;457:480-4
44. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol 2009;587:4153-8
45. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444;1027-31
46. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007;104:979-84
47. Royall D, Wolever TMS, Jeejeebhoy KN. Clinical significance of colonic fermentation. Am J Gastroenterol 1990;85;1307-12
48. Gutzwiller JP, Goke B, Drewe J, et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999;44:81-6
49. Batterham RL, Heffron H, Kapoor S, et al. Critical role for peptide YY in protein-mediated satiation and bodyweight regulation. Cell Metab 2006;4:223-33
50. le Roux CW, Batterham RL, Aylwin SJ, et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006;1:3-8
51. Astrup A, Carraro R, Finer N, et al. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond) 2012;6:843-54
52. Cani PD. Gut Microbiome and obesity. Handbook of Obesity: Clinical Applications. 4th Edition. Volume 2. CRC Press, Boca Raton, FL, USA; 2014
53. Parekh PJ, Arusi E, Vinik AI, Johnson DA. The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome. Front Endocrinol (Lausanne) 2014;5:47
54. Jenkins DJ, Wolever TM, Jenkins A, et al. Specific types of colonic fermentation may raise low-densitylipoprotein-cholesterol concentrations. Am J Clin Nutr 1991;54:141-7
55. Ferrier KE, Muhlmann MH, Baguet JP, et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 2002;39:1020-5
56. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005;45:9-14
57. Zhou MS, Wang A, Yu H. Link between insulin resistance and hypertension: what is the evidence from evolutionary biology Diabetol Metab Syndr 2014;6:12
58. Salvetti A, Brogi G, Di Legge V, Bernini GP. The inter-relationship between insulin resistance and hypertension. Drugs 1993;46:149-59
59. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 2011;6:209-40
60. Boaventura C, Azevedo R, Uetanabaro A, et al. The benefits of probiotics in human and animal nutrition. In: Brzozowski T, editor. New advances in the basic and clinical gastroenterology. InTech, Rijeka, Croatia; 2012. p. 75-100
61. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012;143:913-16
62. Anandharaj M, Sivasankari B, Rani RP. Effects of probiotics, prebiotics, and synbiotics on hypercholesterolemia: a review. Chin J Biol 2014;2014:7
63. Lee YK, Salminen S. Handbook of probiotics and prebiotics. Wiley; New Jersey: 2009
64. Sanchez M, Darimont C, Drapeau V, et al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr 2014;111:1507-19
65. Jones ML, Martoni CJ, Parent M, Prakash S. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr 2012;107:1505-13
66. Luoto R, Kalliomäki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes 2010;34:1531-7
67. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 2002;76:1249-55
68. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 2011;94:3288-94
69. Sadrzadeh-Yeganeh H, Elmadfa I, Djazayery A, et al. The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr 2010;103:1778-83
70. Ataie-Jafari A, Larijani B, Alavi Majd H, Tahbaz F. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann Nutr Metab 2009;54:22-7
71. Xiao JZ, Kondo S, Takahashi N, et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 2003;86:2452-61
72. Agerholm-Larsen L, Raben A, Haulrik N, et al. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000;54:288-97
73. Chang BJ, Park SU, Jang YS, et al. Effect of functional yogurt NY-YP901 in improving the trait of metabolic syndrome. Eur J Clin Nutr 2011;65:1250-5
74. Guo Z, Liu XM, Zhang QX, et al. Influence of consumption of probiotics on the plasma lipid profile: a metaanalysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2011;21:844-50
75. Kadooka Y, Sato M, Imaizumi K, et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 2010;64:636-43
76. Sharafedtinov KK, Plotnikova OA, Alexeeva RI, et al. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients-a randomized double-blind placebo-controlled pilot study. Nutr J 2013;12:138
77. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989;66:365-78
78. Million M, Angelakis E, Paul M, et al. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog 2012;53:100-8
79. Takemura N, Okubo T, Sonoyama K. Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet. Exp Biol Med (Maywood) 2010;235:849-56
80. Sato M, Uzu K, Yoshida T, et al. Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 2008;99:1013-17
81. Park DY, Ahn YT, Huh CS, et al. The inhibitory effect of Lactobacillus plantarum KY1032 cell extract on the adipogenesis of 3T3-L1 Cells. J Med Food 2011;14:670-5
82. Bjerg AT, Kristensen M, Ritz C, et al. Lactobacillus paracasei subsp paracasei L. casei W8 suppresses energy intake acutely. Appetite 2014;82C:111-18
83. Guo Z, Liu XM, Zhang QX, et al. Influence of consumption of probiotics on the plasma lipid profile: a metaanalysis of randomised controlled trials. Nutr Metab Cardiovasc Dis 2011;21:844-50
84. Zhuang G, Liu X-M, Zhang Q-X, et al. Research Advances With Regards to Clinical Outcome and Potential Mechanisms of the Cholesterol-Lowering Effects of Probiotics. Clin Lipidol 2012;7:501-7
85. Noh DO, Gilliland SE. Infuence of bile on cellular integrity and betagalactosidase activity of Lactobacillus acidophilus. J Dairy Sci 1993;76:1253-9
86. Hara H, Haga S, Aoyama Y, Kiriyama S. Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr 1999;129:942-8
87. Eslamparast T, Zamani F, Hekmatdoost A, et al. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. Br J Nutr 2014;112:438-45
88. Firouzi S, Barakatun-Nisak MY, Ismail A, et al. Role of probiotics in modulating glucose homeostasis: evidence from animal and human studies. Int J Food Sci Nutr 2013;64:780-6
89. Ma X, Hua J, Li Z. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 2008;49:821-30
90. Asemi Z, Zare Z, Shakeri H, et al. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 2013;63:1-9
91. Khalesi S, Sun J, Buys N, Jayasinghe R. Effect of probiotics on blood pressure a systematic review and meta-analysis of randomized, controlled trials. Hypertension 2014;64:897-903
92. Mortensen FV, Nielsen H, Mulvany MJ, Hessov I. Short chain fatty acids dilate isolated human colonic resistance arteries. Gut 1990;31:1391-4
93. Pluznick JL, Protzko RJ, Gevorgyan H, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci USA 2013;110:4410-15
94. Lye H-S, Kuan C-Y, Ewe J-A, et al. The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 2009;10:3755-75
95. Bukowska H, Pieczul-Mróz J, Jastrzebska M, et al. Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis 1998;137:437-8
96. Laitinen K, Poussa T, Isolauri E. Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota Group. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomized controlled trial. Br J Nutr 2009;101:1679-87